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Abstract
Objective: The Actiwatch 2 (AW2) is a wrist-worn accelerometer typically used to measure sleep. 
Although it can measure physical activity, there is limited evidence supporting its validity. We
assessed the validity and reliability of the AW2 to measure sedentary behavior and physical
activity (light, moderate, vigorous intensities), and reported their respective count cut-points.
Approach: 28 males and 22 females completed a task battery comprising three sedentary tasks
and six randomized physical activity tasks at varying intensities, whilst wearing the AW2, a 
reference accelerometry device (Actigraph GT3X) and a cardiopulmonary gas analyzer on two
separate occasions. Validity was assessed using correlations (AW2 counts versus GT3X counts
and metabolic equivalent (MET) values), reliability using Bland-Altman analyses, and cut-points 
were determined using Receiver Operating Characteristic Area Under the Curve (AUC) analyses.
Main results: AW2 counts were positively correlated with GT3X counts (rho=0.902, p<0.001) and
METs (rho=0.900, p<0.001). AW2-derived counts were comparable across independent
assessment periods. Sedentary (AUC=0.99, cut-point: 256cpm) and vigorous activity (AUC=0.95, 
cut-point: 720cpm) were strongly characterized, and moderate activity (AUC=0.66, cut-point:
418cpm) was weakly characterized.
Significance: The use of the AW2 in physical activity monitoring looks promising for sedentary
behavior, moderate and vigorous activity, however, further validation is needed.
Keywords: accelerometry; motion sensors; sedentary behavior; physical activity
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Introduction
Wearable devices have gained increasing popularity in health research for their ability to return
continuous objective measures of various health-related outcomes in free-living, habitual
settings.1 Among these outcomes are physical activity and sleep, both of which are important
factors in the prevention and management of chronic diseases, including obesity, hypertension
and type 2 diabetes mellitus.2 At present, many devices exist to independently measure sedentary
behavior, physical activity and sleep. Although it is possible to use multiple devices to 
independently measure parameters of sleep and physical activity, it is not ideal. Thus, a major
challenge has been to identify a single valid and reliable monitoring device capable of measuring
two or more of these variables concurrently.3,4 
Accelerometers are favored as valid and reliable alternatives to traditional methods of objective
physical activity and energy intake monitoring for their practical and non-invasive designs.5,6 
Among the most commonly used accelerometer devices for physical activity monitoring are the
Actigraph GT1M and GT3X model devices (Actigraph, Pensacola, FL, USA).6 Accelerometers are
typically small wearable devices fixed to various points on the body (including the waist, wrist, hip,
thigh or ankle) and can detect gross bodily movement in up to three orthogonal planes: 
anteroposterior, mediolateral and vertical.5 Since the wearer typically receives no visual feedback
relating to their measured physical activity, the risk of participants inadvertently altering or
manipulating their habitual activity patterns is thought to be low.7 The use of accelerometers is
considered a gold-standard approach in the direct assessment of waking (total volume)
movement behavior in free-living settings.8 In addition to wake-time physical activity,
accelerometers are now also used to indirectly monitor sleep patterns in free-living settings.8 
Despite differences in placement (hip-worn for measuring waking movement versus wrist-worn
for measuring sleep),9 the mechanics of sleep and physical activity monitoring by accelerometry
are identical. The devices produce acceleration forces which, after being converted into voltage
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signals, are integrated as an average or peak acceleration according to a user-defined interval
10,11 (or epoch) and are finally reported as arbitrary units called counts. The conversion of raw
accelerations into counts is done by manufacturer-specific algorithms, which may either be
proprietary or open-source. Proprietary algorithms incur additional research challenges as raw
data are often unavailable, meaning counts from one device may not be interpretable or
comparable against those from other devices.10 The premise of these algorithms in physical
activity monitoring is to estimate physiological outcomes, including energy expenditure and the
dose of physical activity exposure at various intensities (i.e., sedentary, light, moderate or
vigorous).12 For sleep monitoring, these algorithms are used to determine sleep-wake intervals
by assessing whether gross motion is indicative of the wearer being awake, using the magnitude
and duration of the acceleration signal.13 
The Actiwatch 2 (AW2; Philips Respironics, Eindhoven, Netherlands) is widely used for research
to directly measure parameters of sleep in free-living settings and has been validated against
polysomnography.8,13,14 While the AW2 is also capable of measuring physical activity using the
native (albeit proprietary) algorithm to produce activity counts, there is limited evidence supporting
its validity in physical activity. To the best of our knowledge, only a few studies have attempted to
validate the AW2 for physical activity monitoring. For example, Neil-Sztramko et al3 validated it’s
use in a convenience sample of mostly older, lean, active female shift workers; and Lee et al15 
validated it using a task menu comprising only treadmill running activities. The extrapolation of
these findings to a broader demographic or the general population, or across a wide range of
activities, however, is limited.
The purpose of this study was to test the validity of a single monitoring device (AW2), usually 
applied to measure sleep patterns, to quantify sedentary behavior and physical activity. This study
expands upon the work by Neil-Sztramko et al3 by including both males and females,
encompassing a younger age range with wide variation in physical fitness. The aims were to (i)
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validate the AW2 as a tool for assessing sedentary behavior and physical activity by comparing
its physical activity counts to both a reference physical activity monitor (Actigraph GT3X) and
energy expenditure using indirect calorimetry, (ii) determine the AW2-derived count cut-points,
maximizing sensitivity and specificity, for sedentary, light, moderate and vigorous physical activity
using metabolic equivalent (MET) and count data, and Receiver Operating Characteristic (ROC)
Curve analyses and (iii) assess the reliability of the AW2 to measure physical activity by
comparing the physical activity counts across two independent assessment periods.
Methods
Participants
Apparently healthy males and females were eligible to participate in the study if they were
between 18 and 60 years of age. Fifty participants with varying levels of physical activity were
recruited through media posting. Participants first underwent health screening using the American
College of Sports Medicine Exercise Pre-Participation Screening criteria16 to ascertain participant
safety during moderate to vigorous physical activity. Participants who answered ‘Yes’ to any of
the questions during the screening process, as well as pregnant women, were excluded due to
health risks and for integrity of cardiometabolic data. Ethical approval was obtained from the
University of Cape Town’s Human Research Ethics Committee (HREC No. 334/2017) and all
participants provided written informed consent. This study was conducted in accordance with the
ethical principles of the Declaration of Helsinki.17 
Procedures
An overview of the study procedures is depicted in Figure 1. All testing was performed at the
Division of Exercise Science and Sports Medicine, University of Cape Town with data collection 
sessions scheduled between 07h00 and 11h00 to control for diurnal intra-individual variability.
Participants were asked not to eat or drink (except water) at least 2h prior to testing, not to
Page 5 of 28
     
 
   
 
               
         
        
        
          
           
        
         
      
 
   
               





























































AUTHOR SUBMITTED MANUSCRIPT - PMEA-103519.R1 Page 6 of 28 
Validation, Reliability & Calibration of the AW2
consume caffeine at least 3h prior to testing and to avoid moderate to vigorous physical activity
at least 6h prior to testing. Participants completed the Global Physical Activity Questionnaire18 to
characterize their habitual physical activity. Outcome variables were moderate-to-vigorous 
physical activity metabolic equivalent hours per week (MET h/wk). The investigator measured
each participant’s height (to the nearest 0.1cm) and weight using a stadiometer and digital scale, 
respectively. Waist circumference measurements (at the level of the umbilicus) were taken in
triplicate using a standard tape measure and averaged. Waist circumference measurements were
missing for four participants. Anthropometric outcome variables were height (m), weight (kg),
waist circumference (cm) and body mass index (kg/m2).
Figure 1. Study procedures overview
All participants were fitted with the AW2, worn on their non-dominant wrist, and GT3X, worn
around the waist on an adjustable belt at hip level, in line with the midline of the thigh. They were
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also fitted with a mask connected to a cardiopulmonary gas analyzer (CPET; Cosmed CPET,
Rome, Italy) for collection of metabolic data. The CPET was calibrated prior to each data collection
session with a 3L calibration syringe and a standard gas mixture of 16% oxygen, 4% carbon
dioxide and the balance nitrogen (BOC Special Gas, Afrox, Cape Town, South Africa).
Sedentary testing included 5min of supine rest, followed by 10min of a simulated resting metabolic
rate (sRMR) test for normalization, and 5min each of sitting and standing. Participants were not
permitted to speak, although they were permitted to listen to music and use their mobile phones
during the supine rest, sitting and standing tasks. During the sRMR test, participants were
required to remain awake, whilst lying still and listening to white noise. Respiratory exchange ratio
data during supine rest were used to confirm fasting states.
Following the sedentary testing, a battery of six randomized physical activity tasks were
performed. Participants exercised at self-selected paces eliciting light, moderate or vigorous
intensities based on their rating of perceived exertion (RPE) scores during the task using the Borg
20-point scale.19 RPE scores of 8±1, 12±1 and 15±1 were used for light, moderate and vigorous
intensity exercise, respectively. Activity tasks comprised self-paced walking (light intensity) and 
jogging (moderate and vigorous intensities) on a treadmill (HP Cosmos treadmill, LE500CE,
Nussdorf-Traunstein, Germany), stationary cycling (moderate and vigorous intensities) on a cycle
ergometer (Wattbike Pro/Trainer, Wattbike Ltd., Nottingham, England) and stepping up and down
a two-step 21cm stepping block (moderate intensity). Each activity was performed for 5min with
at least 2min of rest preceding each task for a total data collection time of approximately 2h. A
subset (n=18) of participants, chosen at random, were asked to return to the laboratory to repeat
baseline and physical activity tasks to assess reliability of the AW2 to measure physical activity.
These repeat sessions (T2) were scheduled 7±1 days after each participant’s initial laboratory
session. Participants were also required to comply with the same pre-test inclusion criteria as the
initial session (T1). 
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Oxygen consumption (VO2, mL/kg/min) was measured continuously using the CPET and values
for each task, for each participant, were subsequently converted to MET values and normalized
using their resting metabolic rate derived from the sRMR test. Both the AW2 and GT3X count
data were collected in 15s epochs and reported as counts per minute (cpm) for physical activity
measurements after processing using Philips Actiware (version 6.0.2) and ActiLife (version
6.10.4) software packages, respectively. Data from the AW2 were synchronized with the GT3X
and Cosmed using event markers which created timestamps in the data.
Data and statistical analyses
Descriptive statistics are presented as mean ± standard deviation, or median and interquartile
range. Normality was assessed using the Shapiro-Wilk test. Differences between gender groups
were analyzed using a Mann-Whitney U test. Data during the activity tasks were collected in 15s
epochs and only data from the 4th and 5th minute of each task were used to ensure steady state
of metabolic data.20 Correlations were performed using Spearman’s rho tests. Receiver operating
characteristic curve (ROC) analysis was used to calculate area under the ROC curve (AUC) so
that count cut-points for the AW2, which maximized sensitivity and specificity, could be
determined for sedentary, light, moderate and vigorous activities, defined as ≤ 1.5 METs, 1.5 ­
3.0 METs, ≥ 3.0 METs and ≥ 6.0 METs, respectively. Count cut-points were subsequently
confirmed with Youden’s J statistic.21 Quantification of predictive accuracy was determined using
effect size equivalencies for AUC, Cohen’s d and r.22 Pairwise comparisons to determine
differences between the AUC under independent ROC curves at varying intensities were also
calculated. Differences in accelerometry and metabolic data between sessions T1 and T2 were
analyzed using a paired-sample t-test or Wilcoxon matched-pair sign-ranked test. Repeatability
of the AW2 to measure physical activity was performed using Bland-Altman analyses.
Significance was accepted at p < 0.05. All data were analyzed using SPSS (IBM Corp., IBM SPSS
Statistics, Version 20.0. Armonk, NY, USA).
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Results
Descriptive characteristics of the 50 participants are presented in Table 1. Their ages ranged from
19 to 59 years, males were taller (p < 0.01), heavier (p < 0.01) and had greater waist
circumferences (p < 0.05) relative to females. The self-reported levels of moderate-vigorous
physical activity during the week were similar among males and females (female range: 0 - 74
MET h/wk, male range: 0 – 44 MET h/wk).




Age (y) 29.5 (18.0) 29.5 (18.0) 29.0 (20.0) 0.822
Weight (kg) 69.9 (15.2) 75.1 (18.2) 67.8 (16.4) 0.004
Height (m) 1.71 ± 0.09 1.77 ± 0.07 1.63 ± 0.05 <0.001
BMI (kg/m2) 24.1 (5.5) 24.1 (5.6) 23.9 (5.7) 0.922
Waist circumference (cm) 78.5 (12.2) a 82.5 (13.8) b 74.5 (12.6) c 0.027
MVPA (MET h/wk) 10.0 (8.7) 10.0 (9.4) 10.0 (8.5) 0.645
Data are presented as mean ± standard deviation or median (interquartile range). BMI: body mass
index; MVPA: moderate-vigorous physical activity; MET: metabolic equivalent. The p value
represents the gender comparison tested using an independent t-test or Mann-Whitney U test.
Waist circumference available for a subset: a n=46; b n=26; c n=20.
MET and count data for each task, as well as correlations between the device counts and METs,
and between the devices themselves are presented in Table 2. While the purpose of the study
was to validate the AW2 device, the correlations between the GT3X counts and MET are 
presented as a comparator for the AW2 v MET correlation. AW2 activity counts were positively
correlated to MET values for the sitting (p = 0.007), standing (p = 0.007), light treadmill walking
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(p = 0.010), moderate treadmill jogging (p < 0.001), vigorous treadmill jogging (p = 0.009), and
vigorous stationary cycling (p = 0.028) tasks. GT3X activity counts were positively correlated with
MET values for the sitting (p = 0.020), light treadmill walking (p < 0.001), moderate treadmill
jogging (p < 0.001), vigorous treadmill jogging (p = 0.001), and moderate stepping (p = 0.009) 
tasks. AW2 and GT3X counts were positively correlated for the moderate treadmill jogging (p =
0.002) and moderate stepping (p = 0.011) tasks. In most cases, the AW2 correlations were weak
but significant, except for correlations for moderate treadmill jogging, which were all moderate
and significant.
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Table 2. Metabolic and count data measured during each task as well as their correlations.
AW2 vs. GT3X vs. AW2 vs.
Task
Predicted Measured AW2 GT3X MET MET GT3X
MET MET (cpm) (cpm)
Spearman’s rho (p value)
Supine rest 1.3 1.1 ± 0.1 8.5 (23.1) 0.0 (0.0) -0.024 (0.869) 0.146 (0.311) 0.014 (0.925)
Sitting 1.5 1.2 ± 0.1 34.8 (68.1) 0.0 (4.1) 0.377 (0.007) 0.328 (0.020) 0.220 (0.126)
Standing 1.8 1.2 ± 0.2 37.8 (79.3) 0.0 (1.0) 0.377 (0.007) 0.177 (0.219) 0.106 (0.465)
Light treadmill walking 3.5 3.3 ± 0.6 484.3 (248.8) 2131.0 (1413.0) 0.359 (0.010) 0.590 (<0.001) 0.063 (0.665)
Moderate treadmill >6.0 6.8 ± 1.4 1749.0 (1529.3) 7601.8 (3497.5) 0.570 (<0.001) 0.574 (<0.001) 0.428 (0.002)
jogging
Vigorous treadmill >6.0 8.3 ± 1.9 2610.1 ± 1140.9 7509.1 ± 2106.6 0.364 (0.009) 0.440 (0.001) 0.120 (0.407)
jogging
Moderate stationary 6.8 4.9 (1.8) 80.0 (119.0) 74.8 (685.8) 0.058 (0.687) -0.081 (0.576) 0.033 (0.820)
cycling
Vigorous stationary 8.8 6.8 (3.2) 219.5 (193.6) 891.5 (1509.1) 0.312 (0.028) -0.045 (0.755) 0.100 (0.490)
cycling
Moderate stepping 7.5 6.0 ± 1.2 712.2 ± 332.2 3206.1 ± 720.1 0.114 (0.431) 0.368 (0.009) 0.355 (0.011)
Data are presented as mean ± standard deviation, median (interquartile range), or Spearman’s rho. MET: metabolic equivalent; AW2:
Actiwatch 2; GT3X: Actigraph GT3X; cpm: counts per minute. Correlations were determined using Spearman’s rho test. Significance was
accepted at p < 0.05.
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Figure 2 displays the correlations for all tasks combined between AW2 and GT3X counts (A and
B), AW2 counts and METs (C and D) and GT3X counts and METs (E and F, for comparison
purposes). The left panel (A, C, E) includes all activities while the right panel excludes the cycling
tasks (B, D, F), since the intensity of the cycling tasks was poorly estimated by both devices
(Table 2). The counts measured by the AW2 were positively correlated with counts measured by
the GT3X regardless of whether cycling was included (Figure 2A, p < 0.001) or excluded (Figure
2B, p < 0.001) from the analyses. Counts measured by the AW2 were positively correlated with
task METs for analyses including (Figure 2C, p < 0.001) and excluding (Figure 2D, p < 0.001) the
cycling tasks. Similarly, counts measured using the GT3X were positively correlated with task
METs for analyses including (Figure 2E, p < 0.001) and excluding (Figure 2F, p < 0.001) the
cycling tasks. In all cases, the strengths of the correlations were improved through removal of the
cycling tasks.
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Figure 2. Correlations between counts measured by the AW2 and GT3X accelerometers (A, B), 
AW2 counts and task MET (C, D) and GT3X counts and task MET (E, F). The left panel includes
all tasks (A, C, E) while the cycling tasks are omitted from the right panel graphs (B, D, F). cpm:
counts per minute; MET: metabolic equivalents. Correlations were determined using Spearman’s
rho test.
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ROC analysis revealed that the AW2’s ability to characterize sedentary activity was strong (AUC
= 0.93, 95% CI: 0.90 to 0.95, p < 0.001) and that using a count cut-point of 99 cpm produced
85.5% sensitivity and 86.6% specificity (Figure 3A). The ability of the AW2 to characterize light
activity was weak (AUC = 0.47, 95% CI: 0.38 to 0.55, p = 0.600), and a cut-point of 578 cpm
elicited a 90.9% sensitivity but 33.9% specificity (Figure 3C). AW2 characterization of moderate
activity was also weak (AUC = 0.58, 95% CI: 0.53 to 0.63, p = 0.007) and a count cut-point of 259
cpm gave 63.0% sensitivity and 56.5% specificity, indicative of high false-positive rates (Figure
3B). While vigorous activity characterization by the AW2 was acceptable (AUC = 0.84, 95% CI:
0.80 to 0.88, p < 0.001), a count cut-point of 400 cpm yielded 72.3% sensitivity and 73.5%
specificity (Figure 3D). Based on the poor sensitivity and specificity for the characterization of light
activity, the ability of the AW2 to reliably determine the cut-points for light activity intensity was
not justified; and are therefore not reported.
The ability of the GT3X to characterize sedentary activity was almost perfect (AUC = 0.97, 95%
CI: 0.95 to 0.98, p < 0.001) using a cut-point of 42 cpm, yielding 99% sensitivity and 89.5%
specificity (Figure 3A). In contrast, the ability of the GT3X to characterize light activity was weak
(AUC = 0.52, 95% CI: 0.45 to 0.60, p = 0.699) using a cut-point of 2328 cpm, produced 90.9%
sensitivity and 39.7% specificity (Figure 3C). Moderate activity was weakly characterized by the
GT3X (AUC = 0.62, 95% CI: 0.56 to 0.67, p < 0.001) using a cut-point of 1442, producing 66.7%
sensitivity and 62.5% specificity. The ability of the GT3X to characterize vigorous activity (AUC =
0.86, 95% CI: 0.82 to 0.89, p < 0.001) was acceptable, and using a cut-point of 2836 cpm, resulted
in 68.2% sensitivity and 84.8% specificity.
A pairwise comparison of AW2 and GT3X ROC curves indicated that there were no differences
between the AUC for light (p = 0.522), moderate (p = 0.419) or vigorous (p = 0.531) cut-points,
except for the AUC for sedentary (p = 0.036) cut-points which were significantly different.
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Figure 3. Receiver operating characteristic (ROC) analyses for sedentary, light, moderate and
vigorous activities for the Actiwatch 2 (solid line) and Actigraph GT3X (dashed line) devices.
Removing cycling tasks from the sample pool improved the ability of the AW2 to characterize 
sedentary activity to nearly perfect (AUC = 0.99, 95% CI: 0.98 to 1.00, p < 0.001) with a count
cut-point of 256 cpm, giving 97.9% sensitivity and 96.6% specificity (Figure 4A). Characterization
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of light activity using the AW2 remained weak (AUC = 0.46, 95% CI: 0.38 to 0.54, p = 0.548) with
a cut-point of 273 cpm, giving 81.0% sensitivity and 45.0% specificity (Figure 4C). AW2
characterization of moderate activity improved but remained weak (AUC = 0.66, 95% CI: 0.60 to
0.71, p < 0.001), with a count cut-point of 418 cpm producing 80.5% sensitivity and 59.7%
specificity (Figure 4B). Characterization of vigorous activity using the AW2 was almost perfect
(AUC = 0.95, 95% CI: 0.93 to 0.97, p < 0.001) with a count cut-point of 720 cpm, yielding 88.2%
sensitivity and 85.1% specificity (Figure 4D).
Similarly, with the cycling tasks removed, the ability of the GT3X to characterize sedentary activity
remained nearly perfect (AUC = 0.99, 95% CI: 0.98 to 1.0, p < 0.001) with a cut-point of 46 cpm,
giving 99.3% sensitivity and 97.8% specificity (Figure 4A). GT3X characterization of light activity
remained weak (AUC = 0.44, 95% CI: 0.37 to 0.50, p = 0.341) with a cut-point of 655 cpm,
producing 71.4% sensitivity and 44.1% specificity (Figure 4C). Characterization of moderate 
activity with the GT3X improved, but remained weak (AUC = 0.65, 95% CI: 0.60 to 0.71, p <
0.001) using a count cut-point of 1585 cpm, producing 93.9% sensitivity and 60.1% specificity
(Figure 4B). Vigorous activity (AUC = 0.96, 95% CI: 0.95 to 0.98, p < 0.001) was characterized
almost perfectly using the GT3X using a cut-point of 3707 cpm, giving 86.3% sensitivity and 91.9%
specificity (Figure 4D).
A pairwise comparison of AW2 and GT3X ROC curves with the cycling tasks excluded yielded no
differences between the AUC for sedentary (p = 0.471), light (p = 0.800), moderate (p = 0.922) or
vigorous (p = 0.384) cut-points.
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Figure 4. Receiver operating characteristic (ROC) analyses for sedentary, light, moderate and
vigorous activities for the Actiwatch 2 (solid line) and Actigraph GT3X (dashed line) devices with
cycling activity tasks omitted.
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A comparison of metabolic and AW2 count data measured on two separate occasions (T1 and
T2) are presented in Table 3. There were no differences in MET values or AW2 counts measured
between T1 and T2. Bland-Altman analyses (Figure 5A - 5I) show the agreement of AW2 counts
in the activity tasks graphically.
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Table 3. Comparison of metabolic and Actiwatch 2 count data measured on two separate occasions (T1 and T2) in
a subset of participants (n=18).
MET AW2 (cpm)
Tasks
T1 T2 p value T1 T2 p value
Supine rest 1.1 ± 0.1 1.1 ± 0.1 0.668 15.0 (30.5) 20.8 (43.0) 0.647
Sitting 1.2 (0.2) 1.1 (0.2) 0.557 35.3 (99.9) 48.8 (63.9) 0.472
Standing 1.2 ± 0.2 1.2 ± 0.2 0.750 35.3 (41.4) 38.5 (73.5) 0.246
Light treadmill walking 3.5 ± 0.5 3.7 ± 0.7 0.205 518.4 ± 179.0 518.5 ± 132.7 0.998
Moderate treadmill jogging 6.9 ± 1.2 7.3 ± 1.6 0.232 2115.0 (1567.5) 2001.5 (1021.1) 0.983
Vigorous treadmill jogging 8.2 ± 1.4 8.5 ± 1.8 0.408 2609.0 (1349.8) 2367.8 (1152.6) 0.845
Moderate stationary cycling 5.1 ± 1.1 5.3 ± 1.3 0.621 64.0 (211.1) 104.0 (214.6) 0.420
Vigorous stationary cycling 6.9 ± 1.8 6.7 ± 1.9 0.658 204.0 (247.0) 178.5 (284.3) 0.396
Moderate stepping 6.1 ± 1.0 6.1 ± 1.0 0.810 720.8 (383.8) 581.3 (307.1) 0.828
Data are presented as mean ± standard deviation or median (interquartile range). MET = metabolic equivalent; AW2 = Actiwatch 2
(presented in counts per minute). Significance was determined using either a paired t-test or Wilcoxon matched-pair signed-rank test.
Significance was accepted at p < 0.05.
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Figure 5. Bland-Altman plots demonstrating agreement in AW2 count data (counts per minute;
cpm) across two independent assessment periods (T1, session 1; T2, session 2) during supine
rest (A), sitting (B), standing (C), light treadmill walking (D), moderate treadmill jogging (E), 
vigorous treadmill jogging (F), moderate stationary cycling (G), vigorous stationary cycling (H)
and moderate stepping (I) activity tasks. The solid line represents the mean (bias) while the dotted
lines represent the upper and lower limits of agreement (LoA, ± 1.96 SD). The difference in AW2
activity counts are plotted on the y-axis, and the mean of the AW2 activity counts across are
plotted on the x-axis.
Discussion
The present study performed a calibration and validation of the AW2 by comparing AW2-derived
physical activity outcomes (counts per minute) against objectively measured oxygen consumption
(MET), and physical activity outcomes of a reference device (GT3X). The calibration component
of the study was performed using ROC curve analyses, and AUC to determine count cut-points
using the native algorithm typically used in the analysis of sleep parameters. Additionally, this
study assessed the reliability of the AW2 to measure physical activity outcomes in an array of
tasks over two independent assessment periods, using Bland-Altman analyses.
By using the native sleep algorithm to predict physical activity outcomes at varying intensities, the
AW2 may be an effective tool to concurrently report on both sleep and physical activity behavior
in a research setting. This may provide physical activity researchers with a broader understanding
of the relationship between sleep and activity during wakeful periods, including: the combined
effect of time spent in sleep, sedentary activity, light and moderate-to-vigorous physical activity
intensities, and dose of the activity exposure. Moreover, the ability of the AW2 to concurrently
deliver meaningful information that is comparable against criterion approaches of sleep, physical
activity and energy expenditure measurements is important to minimize participant burden and
measurement bias.
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Currently there are a limited number of studies assessing physical activity using the AW2
device.3,15 While one study has reported AW2 count cut-points for the measurement of physical
activity at sedentary, light, moderate and vigorous intensities, the findings are limited to
predominantly older (40.0 ± 14.9 years), lean (22.4 ± 3.1 kg/m2), active (37.5 ± 24.5 MET h/wk)
female shift-workers3. The present study sought to expand upon the work of Neil-Sztramko et al3 
by including both male and female participants of varying degrees of cardiorespiratory fitness
from the general population. Moreover, the present study employed an alternative menu of
physical activity tasks (including sedentary and stationary cycle tasks) and used stronger
methodological steps, namely: inclusion of an objective parameter of activity task intensity using
the Borg 20-point scale;19 using a sRMR to determine baseline oxygen consumption in
normalizing metabolic data during ROC analysis to determine MET values (versus using the
Harris-Benedict predicted resting metabolic rate); and confirming participants’ fasted states in
real-time using the CPET to minimize the thermic effect of feeding for metabolic integrity.
The data reported in the present study suggest that the AW2 count cut-points were acceptable
for characterizing sedentary activity (256 cpm) and vigorous (720 cpm) intensity activity. However,
the ability of the AW2 to characterize moderate (418 cpm) intensity activity was weak and it was
unable to characterize light activity. Overall, count data between both AW2 and GT3X monitoring
devices were acceptably correlated with each other, and objective energy expenditure
measurements (MET) suggesting that the AW2 is comparable to a valid and reliable reference
activity monitor, despite differences in the anatomical placement (i.e. wrist- versus waist-worn) of
the respective monitoring devices. Moreover, the AW2 illustrates a high level of reproducibility in
its ability to predict physical activity outcomes during sedentary and active tasks, in a laboratory
environment.
Neil-Sztramko et al3 reported AW2 physical activity count cut-points for sedentary activity and
moderate and vigorous activity intensity of 145 cpm, 274 cpm and 597 cpm, respectively. Light
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intensity count cut-points were reported to be 145 – 274 cpm. These cut-points are lower than the
cut-points reported in the present study and have a stronger ability to discriminate between light
and moderate activity intensities. However, the present study reports cut-points with a stronger
ability to discriminate sedentary activity and vigorous intensity activity. Additionally, correlations
reported in the present study were stronger between AW2 and Actigraph (GT3X/+) counts, and
MET values than those reported by Neil-Sztramko et al3. While the present study did report
positive correlations between individual activity tasks, it is noted that these correlations were
mostly weak, as were similarly reported by Neil-Sztramko et al3.
In addition to performing a calibration of the AW2, this study also reported count cut-points for the
Actigraph GT3X for a qualitative assessment of count data. The Freedson VM3 (2011)23 count
cut-points are among the most frequently used cut-points in physical activity research. The
corresponding count cut-points for physical activity at either light (0 - 2690 cpm), moderate (2691
– 6166 cpm) or vigorous (>6167 cpm) intensity are 655 cpm, 1585 cpm and 3707 cpm,
respectively. Whilst Freedson-reported count cut-points are higher than those measured, it is
thought that discrepancies may be attributed to a small sample size, population bias or procedural
differences. For instance, cycling tasks were found to distort physical activity count data (and
consequently, physical activity intensity and energy expenditure) in both AW2 and GT3X
monitoring devices owing possibly to the static nature of the cycling task, and variability of
reported activity by each device. This is substantiated by an improvement in the strength of
correlations between AW2 and GT3X activity counts with METs respectively (Figure 2) after
cycling tasks were omitted from the analysis. In hindsight, substituting cycling tasks with
alternative habitual lifestyle activity tasks (such as lifting or carrying tasks) may have yielded
superior findings.
The methodological steps in the present study followed best practice recommendations,24 which
included using criterion approaches for energy expenditure (via indirect calorimetry); using a
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broad age range of participants; including both men and women with a range of body mass index
and cardiorespiratory fitness; and a menu of activity tasks spanning a MET range of 1.1 to 10
METs to discriminate sedentary activity, light, moderate and vigorous physical activity. A key
methodological step was having a personalized and objectively measured independent variable 
to compare AW2 and GT3X count data, which was afforded via indirect calorimetry.
Another methodological strength was the comparison of AW2 physical activity count data with a
waist-worn (GT3X) monitor, which is the preferred approach for detection of moderate to vigorous
physical activity intensities.25 The AW2 demonstrated the ability to discriminate vigorous activity
tasks acceptably, despite being wrist-worn. Both AW2 and GT3X devices poorly discriminated
light and moderate intensity activity tasks. It is thought that the inclusion of additional lower
intensity activity tasks may have provided stronger compliance by both devices within these lower
MET ranges (i.e. 1.5 - 6.0 METs).
A major limitation to the data presented is due to a small sample size, which resulted in a loss of
statistical power. While efforts were made to maintain homogeneity between male and female
participants, the cohort was not normally distributed. Moreover, it was not possible to verify
participants’ cardiorespiratory fitness using the subjective physical activity questionnaire,
meaning the broad range of MVPA (MET h/wk) may be the result of misrepresentation of habitual
physical activity. Future work using a larger cohort of participants, comprising a broader
distribution of age and habitual physical activity (or cardiorespiratory fitness) is necessary.
Another major limitation includes using cut-point methods (ROC-AUC) to define intensity
categories. Future work should embrace alternative analytical techniques (such as pattern
recognition analysis) for predicting energy expenditure, which utilizes components of raw
acceleration signals and minimizes the over- or under-representation of energy expenditure.24
Given the variability of tasks performed over a 24h period, or over multiple days, it is also
recommended that future research determine the ability of the AW2 to measure waking movement
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behavior in free-living settings. Given the stringency of controlled laboratory conditions, natural
human movement patterns may have been restricted, and thus not properly reflected in this study
as in a free-living setting.
Conclusion
In conclusion, the count cut-points reported in the present study provides promising evidence for
the use of the AW2 to discriminate between sedentary activity, as well as moderate and vigorous
physical activity intensities in apparently healthy adult males and females. Further work is required
to confirm these findings and to refine best practice recommendations for concurrent sleep and
physical activity data collection in the general population, and in niche cohorts. Further cross-
validation of the AW2 to concurrently measure physical activity of varying intensities, and
parameters of sleep would also aid to broaden the understanding of the combined effect of sleep
and dose exposure to physical activity intensities during wake periods.
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